News | January 25, 2022
Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation
The company has been manufacturing masks since the Covid-19 outbreak in 2020
The company has been manufacturing masks since the Covid-19 outbreak in 2020
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Previously, the use of the drug was limited to patients requiring hospitalization
Biocon has reported consolidated financial results for the period ended December 31, 2021
Quviviq is a dual orexin receptor antagonist, which blocks the binding of the wake-promoting neuropeptides orexins and is thought to turn down overactive wakefulness, as opposed to treatments that generally sedate the brain
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
It is the first monoclonal antibody drug for use in any animal species
Subscribe To Our Newsletter & Stay Updated
